Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
FEBS Lett 437(1-2): 145-148
AOD-9604 is not approved by Health Canada for therapeutic use
Increases SIRT-1 activity as a result of enhanced NAD+ salvage, leading to beneficial epigenetic and metabolic reprogramming, including increased oxidative phosphorylation (OXPHOS) and muscle stem cell activation 1-3
In January, Hims & Hers aired a Super Bowl ad that featured a montage of junk food, abdominal fat, statistics about the health risks of obesity and Big Pharma's high prices
This allows it to pass through the gut lining more effectively and deliver the compound directly into cells rather than losing most of it in the stomach
Neurobiol Aging 32: 2322325
US$ 21.19
US$ 20.65
US$ 24.24
US$ 24.46
US$ 24.31
US$ 29.80
US$ 26.07
US$ 29.40
US$ 28.89
